Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-01-08 @ 6:15 PM
Study NCT ID:
NCT03888105
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-15
First Post:
2019-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
Sponsor:
Regeneron Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | B-cell Non-Hodgkin Lymphoma (B-NHL) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Relapsed B-NHL | View |
| None | Refractory B-NHL | View |
| None | NHL | View |
| None | Follicular lymphoma (FL) | View |
| None | Diffuse large B-cell lymphoma (DLBCL) | View |
| None | Mantle cell lymphoma (MCL) | View |
| None | Marginal zone lymphoma (MZL) | View |
| None | bispecific antibody | View |
| None | CD20 | View |